Topics
-
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
-
Posted the 17th Technology Presentation
-
Business Results Announcement for the Fiscal Year Ending March 31, 2020 (See Latest Financial Statements)
-
Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
-
Implementing the Group’s Social Contribution Activity: “Sysmex Gives Back Day”
-
Business Results Announcement for the Fiscal Year Ending March 31, 2020 (See Latest Financial Statements)
Press Releases
-
Advanced Medical Care Approval for Cancer Gene Panel Testing at the Time of Initial Treatment
- Prospective Study to Assess the Feasibility and Clinical Utility of Comprehensive Genomic Profiling at the Time of Initial Treatment of Patients with Solid Tumors - (PDF：122KB) -
Sysmex Obtains First Marketing Approval in Japan for the Novel Coronavirus Nucleic Acid Detection Kits (RT-PCR Method)
- Aiming for early introduction of test kits for in vitro diagnostic medical devices in medical institutions - (PDF：183KB) - Announcement of Organizational and Personnel Changes (PDF：376KB)
- Sysmex to Introduce New Globally Consistent Job-Based HR Management System with the Aim of Realizing Sustainable Growth
-
Sysmex and the Kobe City Eye Hospital Sign a Comprehensive Collaboration Agreement
-Reinforcing Collaboration toward the Realization of Genomic Medicine in the Area of Ophthalmic Disorders- (PDF：120KB)
